Veritas Genetics Inc:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Veritas Genetics Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C10383
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Veritas Genetics Inc (Veritas Genetics) is a genome sequencing company that offers genomics testing and sequencing products and services. The company delivers actionable genetic insights to individuals and their doctors based on their DNA to manage their disease risk and plan their family health. Its products include myGenome, myBRCA, myBRCA HiRisk, myPrenatal, mycarrier, and myNewborn. Veritas Genetics’ myBRCA HiRisk is a multi-gene test to screen for hereditary breast and ovarian cancer risk. The company works with scientists, physicians, advisors, and patient advocates to design and deliver genetic testing solutions. It also has its presence in Shanghai and Hangzhou, China. Veritas Genetics is headquartered in Danvers, Massachusetts, the US.

Veritas Genetics Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Veritas Genetics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Veritas Genetics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Veritas Genetics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Veritas Genetics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Veritas Genetics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Veritas Genetics Inc, Medical Equipment, Deal Details 10
Venture Financing 10
Veritas Genetics Raises USD1.7 Million in Venture Financing 10
Veritas Genetics Raises USD30 Million in Series B Financing 11
Veritas Genetics Raises USD10 Million in Series A Financing Round 12
Equity Offering 13
Veritas Genetics Raises USD9.6 Million in Financing 13
Acquisition 14
Veritas Genetics Acquires Curoverse 14
Veritas Genetics Inc – Key Competitors 15
Veritas Genetics Inc – Key Employees 16
Veritas Genetics Inc – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 18
Strategy And Business Planning 18
Mar 28, 2018: Veritas Genetics Collaborates with Dr. Steven Narod and Women’s College Hospital to Launch The Screen Project – a Population-Based BRCA Screening Initiative across Canada 18
Corporate Communications 19
Jun 15, 2017: Veritas Genetics Welcomes Dr. Robert C. Green and Dr. Natasha Y. Frank to its Medical & Scientific Advisory Board 19
Feb 08, 2017: Globally Renowned Molecular Genetics Expert, Birgit Funke, PhD, Joins Veritas Genetics as Vice President of Clinical Affairs 20
Legal and Regulatory 21
Jun 01, 2018: Veritas Genetics China Passes CAP & CLIA Inspections for Next Generation Sequencing 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
Veritas Genetics Inc, Medical Equipment, Key Facts 2
Veritas Genetics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Veritas Genetics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Veritas Genetics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Veritas Genetics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Veritas Genetics Inc, Deals By Market, 2012 to YTD 2018 8
Veritas Genetics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Veritas Genetics Raises USD1.7 Million in Venture Financing 10
Veritas Genetics Raises USD30 Million in Series B Financing 11
Veritas Genetics Raises USD10 Million in Series A Financing Round 12
Veritas Genetics Raises USD9.6 Million in Financing 13
Veritas Genetics Acquires Curoverse 14
Veritas Genetics Inc, Key Competitors 15
Veritas Genetics Inc, Key Employees 16
Veritas Genetics Inc, Other Locations 17
Veritas Genetics Inc, Subsidiaries 17

List of Figures
Veritas Genetics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Veritas Genetics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Veritas Genetics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Veritas Genetics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Veritas Genetics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Veritas Genetics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Veritas Genetics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Veritas Genetics Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Veritas Genetics Inc:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • China Resources Sanjiu Medical & Pharmaceutical Co Ltd (000999):製薬・医療:M&Aディール及び事業提携情報
    Summary China Resources Sanjiu Medical & Pharmaceutical Co Ltd (Sanjiu) a subsidiary of China Resources (Holdings) Co., Ltd. researches and develops, manufactures and commercializes pharmaceutical products including traditional Chinese medicine OTC and prescription drugs. Sanjiu’s product portfolio …
  • Centrica Plc (CNA)-エネルギー分野:企業M&A・提携分析
    Summary Centrica plc (Centrica) is an integrated energy company. It carries out electricity generation through and combined cycle gas turbine (CCGT) power stations, and nuclear power plants through its stake in EDF Energy Nuclear Generation. Centrica secures and supply gas and electricity to homes a …
  • Eneva SA (ENEV3):石油・ガス:M&Aディール及び事業提携情報
    Summary Eneva SA (Eneva), formerly MPX Energia SA, is an integrated energy company. The company offers power generation, energy commercialization, and exploration and production of hydrocarbons and natural gas. Its power generation portfolio includes fossil fuels such as coal and natural gas, and re …
  • Meritor, Inc. (MTOR):企業の財務・戦略的SWOT分析
    Meritor, Inc. (MTOR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • KEPCO Plant Service & Engineering Co Ltd (051600):企業の財務・戦略的SWOT分析
    KEPCO Plant Service & Engineering Co Ltd (051600) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key …
  • AIG Europe Limited:企業の戦略・SWOT・財務情報
    AIG Europe Limited - Strategy, SWOT and Corporate Finance Report Summary AIG Europe Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Akari Therapeutics Plc (AKTX):企業の財務・戦略的SWOT分析
    Summary Akari Therapeutics Plc (Akari), formerly Celsus Therapeutics Plc is a biopharmaceutical company. The company is engaged in the development of therapeutic treatments for rare and orphan autoimmune and inflammatory diseases. It offers coversin drugs that act on complement component-C5 that hel …
  • Mitsubishi Tanabe Pharma Corp (4508):製薬・医療:M&Aディール及び事業提携情報
    Summary Mitsubishi Tanabe Pharma Corp (Mitsubishi Tanabe), a subsidiary of Mitsubishi Chemical Holdings Corp, identifies, develops, manufactures, procures and commercializes ethical drugs and over-the-counter (OTC) pharmaceutical products. The company develops ethical drugs for autoimmune disease, d …
  • Volkswind GmbH:企業の戦略的SWOT分析
    Volkswind GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Strong Petrochemical Holdings Ltd:企業の戦略・SWOT・財務情報
    Strong Petrochemical Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Strong Petrochemical Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Reitmans (Canada) Limited (RET.A):企業の財務・戦略的SWOT分析
    Reitmans (Canada) Limited (RET.A) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Eureka Forbes Limited:企業の戦略的SWOT分析
    Eureka Forbes Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Rentschler Biotechnologie GmbH-製薬・医療分野:企業M&A・提携分析
    Summary Rentschler Biotechnologie GmbH (Rentschler), a subsidiary of Dr. Rentschler Holding GmbH & Co KG is a contract development and manufacturing organization that develops and manufactures biopharmaceuticals. The organization offers bioprocess development, biomanufacturing, and consulting servic …
  • VistaGen Therapeutics Inc (VTGN):企業の財務・戦略的SWOT分析
    Summary VistaGen Therapeutics Inc (VistaGen) is a clinical stage biopharmaceutical company that develops new generation medicines for depression and neuropsychiatric disorders. The company’s pipeline product, AV-101, currently under Phase 2 clinical development, is an oral N-methyl-D-aspartate recep …
  • Pioneer Energy Services Corp (PESX):企業の財務・戦略的SWOT分析
    Pioneer Energy Services Corp (PESX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Erasmus MC-医療機器分野:企業M&A・提携分析
    Summary Erasmus MC (Erasmus) is a medical institute that offers patient care, research and educational services. The institute offers graduate and doctoral programs in health sciences, biomedical sciences, molecular medicine and cardiovascular sciences. It conducts research in the areas of biochemis …
  • Roquette Freres SA:企業の戦略的SWOT分析
    Roquette Freres SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Kamada Ltd (KMDA):製薬・医療:M&Aディール及び事業提携情報
    Summary Kamada Ltd (Kamada) is a biopharmaceutical company that develops, manufactures and markets specialty proteins, specific immunoglobulins and other prescription medicines. Its major products include pulmonary related medicines, immunoglobins, vaccines and critical care medicines. It also offer …
  • Beazer Homes USA, Inc.:企業の戦略・SWOT・財務分析
    Beazer Homes USA, Inc. - Strategy, SWOT and Corporate Finance Report Summary Beazer Homes USA, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • AXIS Capital Holdings Limited:戦略・SWOT・企業財務分析
    AXIS Capital Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary AXIS Capital Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆